Press Room

News / Oct 19, 2021

Hovione website wins Digital Communication Awards 2021!

Hovione.com wins GOLD for the best website in the Digital Communication Awards 2021

Hovione website wins Digital Communication Awards DCA 2021

? Hovione wins Best Website Award ?

 

DCA Hovione wins Award - Gold Winner 2021 for Best Website

 

Our website www.hovione.com has been distinguished with the Digital Communication Awards that reward outstanding online projects and campaigns.

 

Our website was ranked as one of the best of over 400 applications and was chosen as a GOLD winner by the jury members in the website category.

 

The new website project that was launched in February 2021 and was described as “100% responsive with a personalized, clean, vibrant design and it is also more inclusive. The content is accessible to visually impaired people who can understand visual content."

 

The new website also presents a chatbot that is ready to answer the first questions in a faster and trendy way. It helps to get closer and provide a better customer experience. The website is user-friendly and lives by our motto - In it for life.

Hovione.COM New Website

The Digital Communication Awards are open to companies and agencies, associations and NGOs, political institutions, and parties from all over the globe since 2011.

 
 

Learn more and find the full list of winners at Digital-Awards.eu

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025